出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年2月
持続可能な医薬品包装市場 : 原材料 (プラスチック、紙と板紙、ガラス、金属)、製品タイプ、プロセス (リサイクル可能、再利用可能、生分解性)、包装タイプ (一次包装)、地域別 – 2027年までの世界予測
Sustainable Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Product Type, Process (Recyclable, Reusable, and Biodegradable), Packaging Type(Primary Packaging), and Region – Global Forecast to 2027
| ページ数 | 278 |
| 図表数 | 272 |
| 種別 | 英文調査報告書 |
| 価格 |
The global Sustainable pharmaceutical packaging market size is projected to grow from USD 71.6 Billion in 2022 to USD 146.3 Billion by 2027, at a CAGR of 15.4% from 2022 to 2027.
Sustainable pharmaceutical packaging is an important aspect of the healthcare industry, as it protects the integrity of the medication and aims to reduce the environmental impact of packaging materials. With an increasing focus on reducing waste and preserving natural resources, pharmaceutical companies are exploring new and innovative ways to create functional and eco-friendly packaging. This includes using recyclable materials, designing for easy recycling, and implementing packaging reduction strategies
“Glass accounted for the third largest share amongst other raw material in the pharmaceutical packaging market.”
Glass is an amorphous and crystalline material with excellent transparency and chemical inertness. It is mainly used in the primary packaging of pharmaceutical drugs. Various types of primary packaging, such as vials, ampoules, bottles, containers, and syringes, are made from glass. Glass is a permanent material that is infinitely recyclable and reusable, reducing waste and saving natural resources. This means that glass has the potential to be recycled over and over again without any loss of its intrinsic properties. Permanent materials are perfect for maintaining a truly circular material loop. Due to the strength of their chemical bonds, permanent materials are not damaged by the recycling process and can stay in the recycling loop as long as they are properly collected, treated, and re-melted.
“secondary packaging to be the second largest pacakging type in molded fiber pulp packaging during the forecast period.”
Secondary packaging in sustainable pharmaceutical packaging refers to the outer packaging that encloses the primary packaging, which contains the actual medication. It protects the primary packaging and provides information about the product, such as the dosage, expiration date, and manufacturer. Secondary packaging is also known as retail-ready packaging (RRP), shelf-ready packaging (SRP), or counter-top display units (CDUs). The packaging makes it easier for retailers to display and handle products. Using sustainable materials in secondary packaging is becoming increasingly important in the pharmaceutical industry as companies aim to reduce their environmental impact.
“Recyclable process accounted for the largest share of sustainable pharmaceutical packaging during the forecast period.”
The use of recyclable plastics in the sustainable pharmaceutical packaging industry is becoming increasingly important as companies and consumers become more aware of the impact of packaging materials. Recyclable plastics, such as PET and HDPE, can be used to create packaging that is not only environmentally friendly but also cost-effective and safe for the storage and transportation of pharmaceutical products. One of the main benefits of using recyclable plastics in pharmaceutical packaging is that it reduces the amount of waste that ends up in landfills. These materials can be easily collected, sorted, and recycled, which helps conserve natural resources and reduce the industry’s carbon footprint. Additionally, recyclable plastics are often lightweight, making them more cost-effective to transport and store. They also have good barrier properties that protect products from moisture, light, and other environmental factors
“Europe is to be the second largest market for sustainable pharmaceutical packaging”
The high demand for pharmaceutical packaging in the region can be attributed to the increasing research, production, and distribution of pharmaceuticals. Significant advancements in the field of medical biopharmaceuticals are further boosting the market in the region. At present, consumers, manufacturers, retailers, advocacy groups, and governments across the region are encouraging environmentally friendly packaging thus contributing to the consistent growth of the sustainable pharmaceutical packaging industry in countries such as Germany, France, and the UK, owing to their environmentally-conscious consumers. All these factors are expected to fuel the demand for sustainable pharmaceutical packaging in the Europe region.
This study has been validated through primaries conducted with various industry experts worldwide. These primary sources have been divided into 3 categories, namely by company, by designation, and by region.
• By Department- Sales/Export/Marketing – 53.5%, Production– 23.3%, CXOs – 23.3%
• By Designation- Managers– 60.5%, CXOs– 23.3%, Executives– 16.3%
• By Region- North America- 33%, Europe- 27%, Asia Pacific- 25%, South America – 5%, and Middle East & Africa – 10%
The key players in the sustaianble pharmaceutical packaging market include Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US).. The study includes an in-depth competitive analysis of these key players in the sustainable pharmaceutical packaging market, with their company profiles, and key market strategies.
Research Coverage
This report provides detailed segmentation of the sustainable pharmaceutical packaging market and forecasts its market size until 2027. The market has been segmented based on raw material, product type, packaging type, process and region. The report also provides detailed information on company profiles and competitive strategies adopted by the key players to strengthen their positions in the market. The report also provides insights into the driving and restraining factors in the sustainable pharmaceutical packaging market, along with opportunities and challenges across these industries. It also includes profiles for top manufacturers in the market.
Reasons to Buy the Report
From an insight perspective, this research report focuses on various levels of analyses — industry analysis (industry trends), market ranking of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the sustainable pharmaceutical packaging market; high growth regions; and market drivers, restraints, opportunities, and challenges
目次
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SEGMENTATION 35
1.3.2 REGIONAL SCOPE 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY CONSIDERED 36
1.6 UNIT CONSIDERED 36
1.7 STAKEHOLDERS 36
1.8 INCLUSIONS AND EXCLUSIONS 37
TABLE 1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS AND EXCLUSIONS 37
1.9 SUMMARY OF CHANGES 37
1.10 LIMITATIONS 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
FIGURE 1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN 39
2.1.1 SECONDARY DATA 40
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key primary insights 42
FIGURE 2 LIST OF STAKEHOLDERS AND BREAKDOWN OF PRIMARY INTERVIEWS 42
2.2 MARKET SIZE ESTIMATION 43
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 43
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 43
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY SIDE 44
2.3 DATA TRIANGULATION 45
FIGURE 6 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION 45
2.4 RESEARCH ASSUMPTIONS 46
2.5 RESEARCH LIMITATIONS 46
2.6 GROWTH FORECAST 46
3 EXECUTIVE SUMMARY 47
FIGURE 7 PLASTICS TO HOLD LARGEST SHARE IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 47
FIGURE 8 PRIMARY PACKAGING TO BE FASTER-GROWING SEGMENT OF SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 48
FIGURE 9 BIODEGRADABLE SEGMENT TO GROW AT HIGHEST CAGR FROM 2022 TO 2027 48
FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 49
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 50
FIGURE 11 EMERGING ECONOMIES TO OFFER ATTRACTIVE OPPORTUNITIES IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 50
4.2 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 50
FIGURE 12 PLASTICS SEGMENT TO REGISTER HIGHEST CAGR FROM 2022 TO 2027 50
4.3 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION AND RAW MATERIAL, 2021 51
FIGURE 13 NORTH AMERICA AND PLASTICS SEGMENT ACCOUNTED FOR LARGEST SHARES 51
4.4 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRIES 52
FIGURE 14 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET IN INDIA TO WITNESS HIGHEST CAGR 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 54
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 54
5.2.1 DRIVERS 54
5.2.1.1 Government initiatives for sustainable packaging 54
5.2.1.2 Consumer preference toward recyclable and eco-friendly materials 55
5.2.1.3 Downsizing of packaging 56
5.2.1.4 Breakthrough in new technologies and innovations 56
5.2.1.5 High growth in generics and biopharmaceuticals markets 57
5.2.2 RESTRAINTS 57
5.2.2.1 Poor infrastructure facilities for recycling 57
5.2.2.2 Lack of awareness of sustainability 57
5.2.2.3 High packaging costs 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Growing demand for primary pharmaceutical packaging 59
5.2.4 CHALLENGES 59
5.2.4.1 Volatile raw material prices 59
5.3 VALUE CHAIN ANALYSIS 60
FIGURE 16 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS 60
5.3.1 RAW MATERIAL SUPPLIERS 60
5.3.2 R&D OF PRODUCTS 60
5.3.3 MANUFACTURERS 61
5.3.4 DISTRIBUTORS 61
5.3.5 END USERS 61
5.3.6 POST-DISPOSAL PROCESS 62
TABLE 2 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKETING: VALUE CHAIN STAKEHOLDERS 63
5.4 PORTER’S FIVE FORCES ANALYSIS 64
FIGURE 17 PORTER’S FIVE FORCES ANALYSIS OF SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 64
5.4.1 THREAT OF NEW ENTRANTS 64
5.4.2 THREAT OF SUBSTITUTES 65
5.4.3 BARGAINING POWER OF BUYERS 65
5.4.4 BARGAINING POWER OF SUPPLIERS 66
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 66
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 66
5.5 REGULATORY LANDSCAPE 67
5.5.1 REGULATIONS 67
5.5.1.1 Europe 67
5.5.1.2 US 67
5.5.1.3 Others 68
5.6 TECHNOLOGY ANALYSIS 68
5.6.1 AUTOMATED RECYCLING 68
5.6.2 EMERGENCE OF TECHNOLOGICALLY ADVANCED RAW MATERIALS 68
5.6.3 NANOTECHNOLOGY 69
5.6.4 PACKAGING FOR BIOLOGICS 69
5.6.5 SMART PACKAGING 69
5.6.6 ANTI-COUNTERFEIT PACKAGING 70
5.6.7 OTHER SMART TRENDS AND TECHNOLOGIES 70
5.7 PRICING ANALYSIS 71
5.7.1 AVERAGE SELLING PRICE, BY REGION 71
FIGURE 18 AVERAGE SELLING PRICE, BY REGION (USD/KG) 71
5.7.2 AVERAGE SELLING PRICE, BY RAW MATERIAL 71
TABLE 4 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG) 71
5.7.3 AVERAGE SELLING PRICE, BY COMPANY 72
TABLE 5 AVERAGE SELLING PRICE, BY COMPANY (USD/KG) 72
5.8 ECOSYSTEM MAPPING 72
FIGURE 19 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 72
5.9 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING MARKET 73
5.9.1 IMPACT ON HEALTHCARE INDUSTRY 73
5.10 IMPACT OF RECESSION ON PHARMACEUTICAL PACKAGING MARKET 74
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75
FIGURE 20 SMART PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE MARKET 75
5.12 PATENT ANALYSIS 75
5.12.1 INTRODUCTION 75
5.12.2 METHODOLOGY 75
5.12.3 DOCUMENT TYPE 76
FIGURE 21 GRANTED PATENTS, LIMITED PATENTS, AND PATENT APPLICATIONS 76
5.12.4 PUBLICATION TRENDS DURING 2011–2021 76
FIGURE 22 NUMBER OF PATENTS DURING 2011–2021 76
5.12.5 INSIGHTS 77
5.12.6 JURISDICTION ANALYSIS 77
FIGURE 23 TOP JURISDICTIONS 77
5.12.7 TOP PATENT APPLICANTS 77
FIGURE 24 TOP 10 PATENT APPLICANTS 78
TABLE 6 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND 78
TABLE 7 LIST OF PATENTS BY SCHOTT AG 79
TABLE 8 LIST OF PATENTS BY TERUMO CORP 79
TABLE 9 LIST OF PATENTS BY BECTON, DICKINSON AND COMPANY 80
TABLE 10 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS 81
5.13 TRADE ANALYSIS 81
5.14 OPERATIONAL DATA 82
5.15 KEY CONFERENCES AND EVENTS IN 2022–2023 83
TABLE 11 KEY CONFERENCES AND EVENTS IN 2022–2023 83
5.16 CASE STUDY ANALYSIS 84
5.16.1 OPTHALMIC SQUEEZE DISPENSER BY APTAR PHARMA TO CONTRIBUTE TO OVERALL ESG COMMITMENTS 84
5.16.2 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY 84
5.16.3 CUSTOM TECHNOLOGY FOR BETTER BREATHING 85
6 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 86
6.1 INTRODUCTION 87
FIGURE 25 PLASTICS TO DOMINATE SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 87
TABLE 12 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING 87
TABLE 13 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 88
TABLE 14 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 89
TABLE 15 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 89
TABLE 16 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 89
TABLE 17 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 90
TABLE 18 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 90
TABLE 19 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 90
TABLE 20 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 91
6.2 PLASTICS 91
6.2.1 COST-EFFECTIVENESS AND EXCELLENT BARRIER PROPERTIES OF PLASTICS TO DRIVE MARKET 91
TABLE 21 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 92
TABLE 22 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 92
TABLE 23 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 92
TABLE 24 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 93
6.2.2 HIGH-DENSITY POLYETHYLENE (HDPE) 93
6.2.3 POLYPROPYLENE (PP) 93
6.2.4 LOW-DENSITY POLYETHYLENE (LDPE) 94
6.2.5 POLYVINYL CHLORIDE (PVC) 94
6.2.6 POLYETHYLENE TEREPHTHALATE (PET) 94
6.2.7 BIO-BASED PLASTICS (BBP) 94
6.2.8 BIODEGRADABLE PLASTICS 95
6.3 PAPER & PAPERBOARD 95
6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO BOOST MARKET 95
TABLE 25 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 96
TABLE 26 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 27 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 96
TABLE 28 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 97
6.4 GLASS 97
6.4.1 EXCELLENT CHEMICAL RESISTANCE AND RECYCLABILITY OF GLASS TO PROPEL MARKET 97
TABLE 29 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 98
TABLE 30 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 98
TABLE 31 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 98
TABLE 32 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 99
TABLE 33 TYPES OF GLASS USED IN PACKAGING 100
6.5 METAL 100
6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET 100
TABLE 34 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 101
TABLE 35 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 101
TABLE 36 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 102
TABLE 37 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 102
6.6 OTHER RAW MATERIALS 103
TABLE 38 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 104
TABLE 39 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 40 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON) 104
TABLE 41 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON) 105
7 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE 106
7.1 INTRODUCTION 106
7.2 PLASTIC BOTTLES 106
7.2.1 EASY OPERABILITY AND SHATTER RESISTANCE OF PLASTIC BOTTLES TO SUPPORT MARKET 106
7.2.2 STANDARD PLASTIC BOTTLES 107
7.2.3 PLASTIC DISPENSING BOTTLES 107
7.2.4 PLASTIC JARS 107
7.3 LABELS & ACCESSORIES 107
7.3.1 PATIENT-DRUG COMMUNICATION COMPLIANCE TO DRIVE MARKET 107
7.3.2 SELF-ADHESIVE LABELS 108
7.3.3 DIE-CUT LABELS 108
7.3.4 TAMPER-PROOF LABELS 108
7.3.5 HOLOGRAPHIC STRIP LABELS 108
7.4 CAPS & CLOSURES 109
7.4.1 PREFERENCE FOR POLYPROPYLENE AND POLYETHYLENE-BASED CAPS & CLOSURES TO FAVOR MARKET GROWTH 109
7.5 MEDICAL SPECIALTY BAGS 109
7.5.1 WIDE USE OF LLDPE AND PE TO CONTRIBUTE TO MARKET GROWTH 109
7.6 PREFILLED SYRINGES 110
7.6.1 HIGH DEMAND IN DEVELOPED AND EMERGING ECONOMIES TO DRIVE MARKET 110
7.7 TEMPERATURE-CONTROLLED PACKAGING 110
7.7.1 INCREASING PRODUCTION OF SPECIALIZED DRUGS TO INFLUENCE MARKET GROWTH POSITIVELY 110
7.8 POUCHES & STRIP PACKS 111
7.8.1 GROWING DEMAND FOR STANDUP POUCHES TO DRIVE MARKET 111
7.9 AMPOULES 111
7.9.1 HIGH DEMAND FROM EMERGING ECONOMIES TO SPUR MARKET GROWTH 111
7.10 VIALS 112
7.10.1 DEMAND FOR VACCINE PACKAGING TO DRIVE MARKET 112
7.11 MEDICATION TUBES 112
7.11.1 GROWTH OF FLEXIBLE PACKAGING IN EMERGING ECONOMIES TO BOOST MARKET 112
7.11.2 COMPOSITE TUBES 113
7.11.3 ALL-PLASTIC TUBES 113
7.11.4 COLLAPSIBLE METAL TUBES 113
7.12 JARS & CANISTERS 113
7.12.1 INCREASING DEMAND FOR PROTECTIVE PACKAGING TO FUEL MARKET 113
7.13 CARTRIDGES 113
7.13.1 BALANCED PACKAGING OFFERED BY CARTRIDGES TO DRIVE MARKET 113
7.14 OTHER TYPES 114
8 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE 115
8.1 INTRODUCTION 116
FIGURE 26 PRIMARY PACKAGING FORMAT TO BE LARGER SEGMENT 116
TABLE 42 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 116
TABLE 43 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 116
8.2 PRIMARY PACKAGING 117
8.2.1 USE OF ALUMINUM OR GLASS TO REDUCE ENVIRONMENTAL IMPACT OF PRIMARY PACKAGING 117
TABLE 44 PRIMARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 117
TABLE 45 PRIMARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 118
8.3 SECONDARY PACKAGING 118
8.3.1 USE OF PLANT-BASED MATERIALS IN SECONDARY PACKAGING TO GAIN MOMENTUM 118
TABLE 46 SECONDARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 119
TABLE 47 SECONDARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 119
9 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS 120
9.1 INTRODUCTION 121
FIGURE 27 RECYCLABLE PROCESS SEGMENT TO BE LARGER SEGMENT 121
TABLE 48 PROCESS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 122
TABLE 49 PROCESS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 122
TABLE 50 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 122
TABLE 51 SUSTAINABLE PLASTIC PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 123
9.2 RECYCLABLE 123
9.2.1 FOCUS OF PACKAGING COMPANIES TO IMPROVE RECYCLING INFRASTRUCTURE TO DRIVE MARKET 123
TABLE 52 RECYCLABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 124
TABLE 53 RECYCLABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 124
9.3 REUSABLE 124
9.3.1 DURABILITY OF TERTIARY PACKAGING TO FUEL MARKET 124
TABLE 54 REUSABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 125
TABLE 55 REUSABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 125
9.4 BIODEGRADABLE 125
9.4.1 INNOVATION TO PLAY KEY ROLE IN BIODEGRADABLE PLASTIC PACKAGING 125
TABLE 56 BIODEGRADABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 126
10 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION 127
10.1 INTRODUCTION 128
FIGURE 28 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR 128
TABLE 57 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION) 129
TABLE 58 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 129
10.2 NORTH AMERICA 129
10.2.1 RECESSION IMPACT 130
FIGURE 29 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 131
TABLE 59 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 132
TABLE 60 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 61 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 132
TABLE 62 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 132
TABLE 63 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 133
TABLE 64 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 133
TABLE 65 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 133
TABLE 66 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 134
TABLE 67 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 134
TABLE 68 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 134
10.2.2 US 135
10.2.2.1 Environmental responsibility to drive market 135
TABLE 69 US: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 135
TABLE 70 US: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 136
10.2.3 CANADA 136
10.2.3.1 Government initiative to reduce overall quantity of packaging waste to boost market 136
TABLE 71 CANADA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 137
TABLE 72 CANADA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 137
10.2.4 MEXICO 137
10.2.4.1 Gradual economic recovery to support market 137
TABLE 73 MEXICO: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 138
TABLE 74 MEXICO: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 138
10.3 ASIA PACIFIC 138
10.3.1 RECESSION IMPACT 139
FIGURE 30 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 140
TABLE 75 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 141
TABLE 76 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 77 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 141
TABLE 78 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 142
TABLE 79 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 142
TABLE 80 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 142
TABLE 81 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 143
TABLE 82 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 143
TABLE 83 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 143
TABLE 84 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 144
10.3.2 CHINA 144
10.3.2.1 Increasing awareness of eco-friendly, sustainable, and renewable packaging to drive market 144
TABLE 85 CHINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 145
TABLE 86 CHINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 145
10.3.3 JAPAN 146
10.3.3.1 Increasing demand for generic drugs to propel market 146
TABLE 87 JAPAN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 147
TABLE 88 JAPAN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 147
10.3.4 SOUTH KOREA 147
10.3.4.1 Well-developed healthcare industry and presence of major pharmaceutical manufacturers to drive market 147
TABLE 89 SOUTH KOREA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 148
TABLE 90 SOUTH KOREA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 148
10.3.5 INDIA 149
10.3.5.1 Increasing domestic consumption and export of generic drugs to fuel market 149
TABLE 91 INDIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 149
TABLE 92 INDIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 150
10.3.6 AUSTRALIA 150
10.3.6.1 PBS schemes to strengthen pharmaceutical industry 150
TABLE 93 AUSTRALIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 151
TABLE 94 AUSTRALIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 151
10.3.7 REST OF ASIA PACIFIC 151
TABLE 95 REST OF ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 152
TABLE 96 REST OF ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 152
10.4 EUROPE 152
10.4.1 RECESSION IMPACT 153
TABLE 97 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 153
TABLE 98 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
TABLE 99 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 154
TABLE 100 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 154
TABLE 101 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 154
TABLE 102 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 154
TABLE 103 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 155
TABLE 104 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 155
TABLE 105 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 155
TABLE 106 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 156
10.4.2 GERMANY 156
10.4.2.1 Government initiatives for boosting recycling rate to drive market 156
TABLE 107 GERMANY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 157
TABLE 108 GERMANY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 157
10.4.3 FRANCE 157
10.4.3.1 High demand for generic drugs to drive market 157
TABLE 109 FRANCE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 158
TABLE 110 FRANCE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 158
10.4.4 ITALY 158
10.4.4.1 Growing exports of pharmaceuticals to boost market 158
TABLE 111 ITALY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 159
TABLE 112 ITALY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 159
10.4.5 UK 159
10.4.5.1 Innovations in drug manufacturing to increase demand 159
TABLE 113 UK: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 160
TABLE 114 UK: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 160
10.4.6 SPAIN 160
10.4.6.1 Macroeconomic factors to have positive impact on market 160
TABLE 115 SPAIN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 161
TABLE 116 SPAIN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 161
10.4.7 RUSSIA 161
10.4.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market 161
TABLE 117 RUSSIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 162
TABLE 118 RUSSIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 162
10.4.8 REST OF EUROPE 162
TABLE 119 REST OF EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 163
TABLE 120 REST OF EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 163
10.5 MIDDLE EAST & AFRICA 163
10.5.1 RECESSION IMPACT 164
TABLE 121 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 164
TABLE 122 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 165
TABLE 123 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 165
TABLE 124 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 165
TABLE 125 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 165
TABLE 126 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 166
TABLE 127 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 166
TABLE 128 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 166
TABLE 129 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 167
TABLE 130 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 167
10.5.2 SAUDI ARABIA 167
10.5.2.1 Wider access to healthcare services to increase demand for pharmaceuticals 167
TABLE 131 SAUDI ARABIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 168
TABLE 132 SAUDI ARABIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 168
10.5.3 SOUTH AFRICA 169
10.5.3.1 Gradual rise in generic drug use to fuel market 169
TABLE 133 SOUTH AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 169
TABLE 134 SOUTH AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 170
10.5.4 UAE 170
10.5.4.1 Increasing initiatives for domestic pharmaceutical production to drive market 170
TABLE 135 UAE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 170
TABLE 136 UAE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 171
10.5.5 REST OF MIDDLE EAST & AFRICA 171
TABLE 137 REST OF MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 171
TABLE 138 REST OF MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 172
10.6 SOUTH AMERICA 172
10.6.1 RECESSION IMPACT 173
TABLE 139 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 173
TABLE 140 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 141 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION) 173
TABLE 142 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION) 174
TABLE 143 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 174
TABLE 144 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 174
TABLE 145 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION) 175
TABLE 146 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION) 175
TABLE 147 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON) 175
TABLE 148 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON) 176
10.6.2 BRAZIL 176
10.6.2.1 Free and universal healthcare services to support pharmaceutical industry 176
TABLE 149 BRAZIL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 177
TABLE 150 BRAZIL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 177
10.6.3 ARGENTINA 177
10.6.3.1 Increasing awareness and development of recycling facilities to drive market 177
TABLE 151 ARGENTINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 178
TABLE 152 ARGENTINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 178
10.6.4 REST OF SOUTH AMERICA 178
TABLE 153 REST OF SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION) 179
TABLE 154 REST OF SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION) 179
11 COMPETITIVE LANDSCAPE 180
11.1 OVERVIEW 180
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 180
TABLE 155 COMPANIES ADOPTED INVESTMENT & EXPANSION AND PRODUCT LAUNCH AS KEY GROWTH STRATEGIES BETWEEN 2019 AND 2022 180
11.3 MARKET EVALUATION MATRIX 182
TABLE 156 MARKET EVALUATION MATRIX 183
11.4 REVENUE ANALYSIS 183
TABLE 157 REVENUE OF KEY COMPANIES DURING 2019–2021 183
11.5 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2021 184
FIGURE 31 RANKING OF TOP 5 PLAYERS IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, 2021 184
11.5.1 BERRY GLOBAL INC. 184
11.5.2 AMCOR PLC 184
11.5.3 APTARGROUP, INC. 184
11.5.4 GERRESHEIMER AG 185
11.5.5 SCHOTT AG 185
11.6 MARKET SHARE ANALYSIS 185
FIGURE 32 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2021) 185
TABLE 158 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION 186
11.7 COMPANY EVALUATION MATRIX (TIER-1 PLAYERS) 186
11.7.1 STARS 186
11.7.2 PERVASIVE PLAYERS 186
11.7.3 EMERGING LEADERS 186
11.7.4 PARTICIPANTS 186
FIGURE 33 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR TIER-1 COMPANIES, 2021 187
11.8 STRENGTH OF PRODUCT PORTFOLIO (TIER-1 PLAYERS) 188
11.9 BUSINESS STRATEGY EXCELLENCE (TIER-1 PLAYERS) 188
11.10 START-UP AND SME MATRIX 189
11.10.1 PROGRESSIVE COMPANIES 189
11.10.2 RESPONSIVE COMPANIES 189
11.10.3 STARTING BLOCKS 189
11.10.4 DYNAMIC COMPANIES 189
FIGURE 34 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS AND SMES, 2021 190
11.11 STRENGTH OF PRODUCT PORTFOLIO (START-UPS AND SMES) 191
11.12 BUSINESS STRATEGY EXCELLENCE (START-UPS AND SMES) 191
11.13 COMPETITIVE BENCHMARKING 192
TABLE 159 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES 192
11.13.1 COMPANY TYPE FOOTPRINT 193
TABLE 160 OVERALL TYPE FOOTPRINT 193
11.13.2 COMPANY REGION FOOTPRINT 195
TABLE 161 OVERALL REGION FOOTPRINT 195
11.13.3 COMPANY FOOTPRINT 196
TABLE 162 OVERALL COMPANY FOOTPRINT 196
11.14 COMPETITIVE SITUATION AND TRENDS 197
11.14.1 PRODUCT LAUNCHES 197
TABLE 163 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES, 2019–2022 197
11.14.2 DEALS 202
TABLE 164 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2022 202
11.14.3 OTHER DEVELOPMENTS 209
TABLE 165 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS, 2019–2021 209
12 COMPANY PROFILES 213
(Business Overview, Products Offered, Recent Developments, Sustainability goals, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS 213
12.1.1 BERRY GLOBAL INC. 213
TABLE 166 BERRY GLOBAL INC.: COMPANY OVERVIEW 213
FIGURE 35 BERRY GLOBAL INC.: COMPANY SNAPSHOT 214
TABLE 167 BERRY GLOBAL INC.: PRODUCTS OFFERED 214
TABLE 168 BERRY GLOBAL INC.: PRODUCT LAUNCHES 215
TABLE 169 BERRY GLOBAL INC.: DEALS 217
TABLE 170 BERRY GLOBAL INC.: OTHER DEVELOPMENTS 218
12.1.2 GERRESHEIMER AG 221
TABLE 171 GERRESHEIMER AG: COMPANY OVERVIEW 221
FIGURE 36 GERRESHEIMER AG: COMPANY SNAPSHOT 222
TABLE 172 GERRESHEIMER AG: PRODUCTS OFFERED 222
TABLE 173 GERRESHEIMER AG: PRODUCT LAUNCHES 224
TABLE 174 GERRESHEIMER AG: DEALS 225
TABLE 175 GERRESHEIMER AG: OTHER DEVELOPMENTS 225
12.1.3 AMCOR PLC 228
TABLE 176 AMCOR PLC: COMPANY OVERVIEW 228
FIGURE 37 AMCOR PLC: COMPANY SNAPSHOT 229
TABLE 177 AMCOR PLC: PRODUCTS OFFERED 229
TABLE 178 AMCOR PLC: PRODUCT LAUNCHES 231
TABLE 179 AMCOR PLC: DEALS 232
TABLE 180 AMCOR PLC: OTHER DEVELOPMENTS 233
12.1.4 SCHOTT AG 235
TABLE 181 SCHOTT AG: COMPANY OVERVIEW 235
FIGURE 38 SCHOTT AG: COMPANY SNAPSHOT 236
TABLE 182 SCHOTT AG: PRODUCTS OFFERED 236
TABLE 183 SCHOTT AG: PRODUCT LAUNCHES 237
TABLE 184 SCHOTT AG: DEALS 237
TABLE 185 SCHOTT AG: OTHER DEVELOPMENTS 238
12.1.5 APTARGROUP, INC. 240
TABLE 186 APTARGROUP, INC.: COMPANY OVERVIEW 240
FIGURE 39 APTARGROUP, INC.: COMPANY SNAPSHOT 241
TABLE 187 APTARGROUP, INC.: PRODUCTS OFFERED 241
TABLE 188 APTARGROUP, INC.: PRODUCT LAUNCHES 242
TABLE 189 APTARGROUP, INC.: DEALS 243
TABLE 190 APTARGROUP, INC.: OTHER DEVELOPMENTS 243
12.1.6 BECTON, DICKINSON AND COMPANY 245
TABLE 191 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 245
FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 246
TABLE 192 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 246
TABLE 193 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES 247
TABLE 194 BECTON, DICKINSON AND COMPANY: DEALS 247
12.1.7 WESTROCK COMPANY 249
TABLE 195 WESTROCK COMPANY: COMPANY OVERVIEW 249
FIGURE 41 WESTROCK COMPANY: COMPANY SNAPSHOT 250
TABLE 196 WESTROCK COMPANY: PRODUCTS OFFERED 250
TABLE 197 WESTROCK COMPANY: DEALS 251
12.1.8 NIPRO CORPORATION 254
TABLE 198 NIPRO CORPORATION: COMPANY OVERVIEW 254
FIGURE 42 NIPRO CORPORATION: COMPANY SNAPSHOT 254
TABLE 199 NIPRO CORPORATION: PRODUCTS OFFERED 255
TABLE 200 NIPRO CORPORATION: DEALS 255
12.1.9 CATALENT, INC. 256
TABLE 201 CATALENT, INC.: COMPANY OVERVIEW 256
FIGURE 43 CATALENT, INC.: COMPANY SNAPSHOT 256
TABLE 202 CATALENT, INC.: PRODUCTS OFFERED 257
TABLE 203 CATALENT, INC.: DEALS 257
TABLE 204 CATALENT, INC.: OTHER DEVELOPMENTS 258
12.1.10 SEALED AIR CORPORATION 259
TABLE 205 SEALED AIR CORPORATION: COMPANY OVERVIEW 259
FIGURE 44 SEALED AIR CORPORATION: COMPANY SNAPSHOT 259
TABLE 206 SEALED AIR CORPORATION: PRODUCTS OFFERED 260
TABLE 207 SEALED AIR CORPORATION: PRODUCT LAUNCHES 260
TABLE 208 SEALED AIR CORPORATION: DEALS 261
12.1.11 WEST PHARMACEUTICAL SERVICES, INC. 263
TABLE 209 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW 263
FIGURE 45 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT 263
TABLE 210 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS OFFERED 264
TABLE 211 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES 265
TABLE 212 WEST PHARMACEUTICAL SERVICES, INC.: DEALS 265
TABLE 213 WEST PHARMACEUTICAL SERVICES, INC.: OTHER DEVELOPMENTS 265
12.2 OTHER PLAYERS 267
12.2.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG 267
TABLE 214 ALPLA WERKE ALWIN LEHNER GMBH & CO KG: COMPANY OVERVIEW 267
12.2.2 ARDAGH GROUP S.A. 268
TABLE 215 ARDAGH GROUP S.A.: COMPANY OVERVIEW 268
12.2.3 CCL INDUSTRIES INC. 269
TABLE 216 CCL INDUSTRIES INC.: COMPANY OVERVIEW 269
12.2.4 FRANK NOE EGYPT LTD. 270
TABLE 217 FRANK NOE EGYPT LTD.: COMPANY OVERVIEW 270
12.2.5 GAPLAST GMBH 270
TABLE 218 GAPLAST GMBH: COMPANY OVERVIEW 270
12.2.6 LONZA GROUP LTD. 271
TABLE 219 LONZA GROUP LTD.: COMPANY OVERVIEW 271
12.2.7 MONDI GROUP 272
TABLE 220 MONDI GROUP: COMPANY OVERVIEW 272
12.2.8 NOLATO AB 273
TABLE 221 NOLATO AB: COMPANY OVERVIEW 273
12.2.9 ORIGIN PHARMA PACKAGING 273
TABLE 222 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW 273
12.2.10 COMAR 274
TABLE 223 COMAR: COMPANY OVERVIEW 274
12.2.11 BILCARE LIMITED 275
TABLE 224 BILCARE LIMITED: COMPANY OVERVIEW 275
12.2.12 SGD PHARMA 276
TABLE 225 SGD PHARMA: COMPANY OVERVIEW 276
12.2.13 SILGAN HOLDINGS INC. 277
TABLE 226 SILGAN HOLDINGS INC.: COMPANY OVERVIEW 277
12.2.14 VETTER PHARMA INTERNATIONAL GMBH 278
TABLE 227 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW 278
*Details on Business Overview, Products Offered, Recent Developments, Sustainability goals, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 279
13.1 DISCUSSION GUIDE 279
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 283
13.3 RELATED REPORTS 285
13.4 AUTHOR DETAILS 286